UNIZOL 200mg/100 ml price in UAE

Overview

Welcome to Dwaey, specifically on UNIZOL 200mg/100 ml Solution for Intravenous Infusion page.
This medicine contains an important and useful components, as it consists of Fluconazole.
UNIZOL 200mg/100 ml is available in the market in concentration 2mg/ml and in the form of Solution for Intravenous Infusion.

MS PHARMA PARTNERS HOLDING WLL is the producer of UNIZOL 200mg/100 ml and it is imported from UAE, The most popular alternatives of UNIZOL 200mg/100 ml are listed downward .

Mode Of Action

Fluconazole decreases ergosterol synthesis by interfering w/ cytochrome P450 activity, thus inhibiting cell membrane formation of susceptible fungi including B. dermatitidis, Candida spp., C. immitis, C. neoformans, Epidermophyton spp., H. capsulatum, Micosporum spp., Trichophyton spp.

Indication

Cryptococcal meningitis
Candidiasis
Tinea pedis
Tinea cruris
Tinea corporis
Vaginal candidiasis
Onychomycosis
Coccidioidomycosis
Cryptococcosis
Histoplasmosis
Mucosal candidiasis
Candidal balanitis
Dermatophytosis

Precaution

Renal or hepatic impairment. May prolong QT interval. Pregnancy, lactation. CDC guidelines recommend only using topical antifungal products to treat pregnant women with vulvovaginal yeast infections, including for longer periods than usual if these infections persist or recur. Lactation Enters breast milk; use caution

Side Effects

>10% Headache (2-13%) 1-10% Nausea (2-7%)
Abdominal pain (2-6%)
Diarrhea (2-3%)
Rash (2%)
Vomiting (2-5%) Frequency Not Defined QT prolongation
Torsades de pointes
Alopecia
Anaphylactic reactions
Angioedema
Cholestasis
Dizziness
Dyspnea
Hepatic failure
Hepatitis
Hypertriglyceridemia
Hypokalemia
Increased alkaline phosphatase
Increased ALT/AST
Jaundice
Leukopenia
Pallor
Seizures
Stevens-Johnson syndrome
Taste perversion
Thrombocytopenia
Toxic epidermal necrolysis Potentially Fatal: Hepatotoxicity; rarely anaphylaxis; Stevens-Johnson syndrome.

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Interaction

May increase plasma concentrations of oral hypoglycaemics (e.g. tolbutamide, glyburide, glipizide), phenytoin, theophylline, tofacitinib, rifabutin. May increase prothrombin time w/ anticoagulants. May cause significant increase in ciclosporin levels in renal transplant patients w/ or w/o renal impairment. Rifampicin reduces fluconazole levels. May increase risk of nephrotoxicity w/ tacrolimus. May increase the effect of short-acting benzodiazepines (e.g. midazolam). Potentially Fatal: Increased risk of cardiac arrhythmias or QT prolongation w/ terfenadine, cisapride, astemizole, pimozide, quinidine, halofantrine and erythromycin.